Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
editorial
. 1978 Feb 25;1(6111):460–461.

Cannabis and the cardiovascular system.

PMCID: PMC1603166  PMID: 626834

Full text

PDF
460

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beaconsfield P., Ginsburg J., Rainsbury R. Marihuana smoking. Cardiovascular effects in man and possible mechanisms. N Engl J Med. 1972 Aug 3;287(5):209–212. doi: 10.1056/NEJM197208032870501. [DOI] [PubMed] [Google Scholar]
  2. Benowitz N. L., Jones R. T. Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion. Clin Pharmacol Ther. 1975 Sep;18(3):287–297. doi: 10.1002/cpt1975183287. [DOI] [PubMed] [Google Scholar]
  3. Benowitz N. L., Jones R. T. Prolonged delta-9-tetrahydrocannabinol ingestion. Effects of sympathomimetic amines and autonomic blockades. Clin Pharmacol Ther. 1977 Mar;21(3):336–342. doi: 10.1002/cpt1977213336. [DOI] [PubMed] [Google Scholar]
  4. Cavero I., Buckley J. P., Jandhyala B. S. Hemodynamic and myocardial effects of (-)-delta9-trans-tetrahydrocannabinol in anesthetized dogs. Eur J Pharmacol. 1973 Nov;24(2):243–251. doi: 10.1016/0014-2999(73)90078-2. [DOI] [PubMed] [Google Scholar]
  5. Domino E. F., Rennick P., Pearl J. H. Dose-effect relations of marijuana smoking on various physiological parameters in experienced male users. Observations on limits of self-titration of intake. Clin Pharmacol Ther. 1974 May;15(5):514–520. doi: 10.1002/cpt1974155514. [DOI] [PubMed] [Google Scholar]
  6. Graham J. D., Li D. M. Cardiovascular and respiratory effects of cannabis in cat and rat. Br J Pharmacol. 1973 Sep;49(1):1–10. [PMC free article] [PubMed] [Google Scholar]
  7. Hardman H. F., Domino E. F., Seevers M. H. General pharmacological actions of some synthetic tetrahydrocannabinol derivatives. Pharmacol Rev. 1971 Dec;23(4):295–315. [PubMed] [Google Scholar]
  8. Hollister L. E. Actions of various marihuana derivatives in man. Pharmacol Rev. 1971 Dec;23(4):349–357. [PubMed] [Google Scholar]
  9. Hosko M. J., Kochar M. S., Wang R. I. Effects of orally administered delta-9-tetrahydrocannabinol in man. Clin Pharmacol Ther. 1973 May-Jun;14(3):344–352. doi: 10.1002/cpt1973143344. [DOI] [PubMed] [Google Scholar]
  10. Johnson S., Domino E. F. Some cardiovascular effects of marihuana smoking in normal volunteers. Clin Pharmacol Ther. 1971 Sep-Oct;12(5):762–768. doi: 10.1002/cpt1971125762. [DOI] [PubMed] [Google Scholar]
  11. Kanakis C., Jr, Pouget J. M., Rosen K. M. The effects of delta-9-tetrahydrocannabinol (cannabis) on cardiac performance with and without beta blockade. Circulation. 1976 Apr;53(4):703–707. doi: 10.1161/01.cir.53.4.703. [DOI] [PubMed] [Google Scholar]
  12. Kiplinger G. F., Manno J. E., Rodda B. E., Forney R. B. Dose-response analysis of the effects of tetrahydrocannabinol in man. Clin Pharmacol Ther. 1971 Jul-Aug;12(4):650–657. doi: 10.1002/cpt1971124650. [DOI] [PubMed] [Google Scholar]
  13. Kochar M. S., Hosko M. J. Electrocardiographic effects of marihuana. JAMA. 1973 Jul 2;225(1):25–27. [PubMed] [Google Scholar]
  14. Lemberger L., McMahon R., Archer R., Matsumoto K., Rowe H. Pharmacologic effects and physiologic disposition of delta 6a,10a dimethyl heptyl tetrahydrocannabinol (DMHP) in man. Clin Pharmacol Ther. 1974 Apr;15(4):380–386. doi: 10.1002/cpt1974154380. [DOI] [PubMed] [Google Scholar]
  15. Lemberger L., Rowe H. Clinical pharmacology of nabilone, a cannabinol derivative. Clin Pharmacol Ther. 1975 Dec;18(6):720–726. doi: 10.1002/cpt1975186720. [DOI] [PubMed] [Google Scholar]
  16. Paton W. D. Pharmacology of marijuana. Annu Rev Pharmacol. 1975;15:191–220. doi: 10.1146/annurev.pa.15.040175.001203. [DOI] [PubMed] [Google Scholar]
  17. Perez-Reyes M., Lipton M. A., Timmons M. C., Wall M. E., Brine D. R., Davis K. H. Pharmacology of orally administered 9 -tetrahydrocannabinol. Clin Pharmacol Ther. 1973 Jan-Feb;14(1):48–55. doi: 10.1002/cpt197314148. [DOI] [PubMed] [Google Scholar]
  18. Prakash R., Aronow W. S., Warren M., Laverty W., Gottschalk L. A. Effects of marihuana and placebo marihuana smoking on hemodynamics in coronary disease. Clin Pharmacol Ther. 1975 Jul;18(1):90–95. doi: 10.1002/cpt197518190. [DOI] [PubMed] [Google Scholar]
  19. Renault P. F., Schuster C. R., Freedman D. X., Sikic B., de Mello D. N. Repeat administration of marihuana smoke to humans. Arch Gen Psychiatry. 1974 Jul;31(1):95–102. doi: 10.1001/archpsyc.1974.01760130071012. [DOI] [PubMed] [Google Scholar]
  20. Tashkin D. P., Levisman J. A., Abbasi A. S., Shapiro B. J., Ellis N. M. Short-term effects of smoked marihuana on left ventricular function in man. Chest. 1977 Jul;72(1):20–26. doi: 10.1378/chest.72.1.20. [DOI] [PubMed] [Google Scholar]
  21. Vollmer R. R., Cavero I., Ertel R. J., Solomon T. A., Buckley J. P. Role of the central autonomic nervous system in the hypotension and bradycardia induced by (-)-delta 9-trans-tetrahydrocannabinol. J Pharm Pharmacol. 1974 Mar;26(3):186–192. doi: 10.1111/j.2042-7158.1974.tb09252.x. [DOI] [PubMed] [Google Scholar]
  22. Weiss J. L., Watanabe A. M., Lemberger L., Tamarkin N. R., Cardon P. V. Cardiovascular effects of delta-9-tetrahydrocannabinol in man. Clin Pharmacol Ther. 1972 Sep-Oct;13(5):671–684. doi: 10.1002/cpt1972135part1671. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES